Baylis Medical Company Overview
Pro stress-test →Baylis Medical is a leader in the development and commercialization of innovative medical devices in the fields of cardiology and spine. The company provides radiofrequency systems for pain management, cardiology perforation, and radiology obtrusion RF devices. Headquartered in Canada with offices worldwide, its clinical solutions have been improving lives for over 30 years.
Strategic Profile
Pro stress-test →Baylis Medical was acquired by Boston Scientific in October 2021 for US $1.75 billion. Though acquired, the company continues to operate as a specialized medical device manufacturer. The founders remain actively involved in the broader Canadian medical device ecosystem, making strategic investments in emerging companies.
Competitive Landscape
Pro stress-test →Baylis Medical competes in cardiology and spine medical devices. Direct competitors include Boston Scientific's other cardiology divisions, Abbott's rhythm management and vascular businesses, and specialized medtech players focused on transseptal access, radiofrequency ablation, and pain management solutions. Baylis's transseptal and RF platform expertise positions it against both large diversified medtech companies and focused niche competitors.
Industry Context
Baylis Medical Company operates in Cardiology and interventional devices.
Key facts
Founded: 1986 · Headquarters: Montreal, Quebec, Canada · Employees: 119 · Revenue: $6.5M (2026, per available data) · Market cap: N/A (Subsidiary of Boston Scientific)